DUALITY BIOTHERAPEUTICS, INC. - B
(HKEX: 9606)
Duality Biotherapeutics, Inc. operates as a clinical stage company. It focuses on the development of next generation antibody-drug conjugate therapeutics and duality immune toxin antibody conjugate therapeutic. The company was founded by Zhu Zhong Yuan on July 3, 2019 and is headquartered in Shanghai, China.
337.200 -
-11.800
(-3.38%)
Range
336.600 - 350.800
(4.22%)
Open
345.000
Previous Close
349.000
Bid Price
336.800
Bid Volume
('000)
0.6
Ask Price
337.200
Ask Volume
('000)
1.2
Volume
('000)
248.3
Value
84,929,344
Remark
-
Delayed prices. Updated at 29 Jan 2026 14:54.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
